Magellan Biologics

SME

Magellan Biologics

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

Magellan Biologics

Address

Torres Novas, AM Lisboa, Portugal

Contact

info@magellanbiologics.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with Magellan Biologics

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Magellan Biologics last news

05/12/2023

Toripalimab-tpzi: the monoclonalantibodies approved by fda this year

Toripalimab-tpzi is another of the #monoclonalantibodies approved by #fda this year, to treat recurrent or #metastatic nasopharyngeal #carcinoma when used together with or following other therapies* It is expressed in a recombinant Chinese Hamster Ovary (#CHO) mammalian cell expression system, reminding again, if still needed, the importance of CHO cells in producing the #drugs of today and tomorrow and demonstrating the intense activity of research and […]

07/11/2023

The CHO 4Tx® system: a strong ally to produce the proteins you need to screen

Quite often, we're asked if the three CHO 4Tx® media can be used separately and independently from one another. �� and the answer is, of course, �� yes… but,�� each of them has been optimized to complement the others,�� each of them has a well defined role in a thorough, highly innovative, transient transfection protocol�� each of […]

18/10/2023

Magellan Biologics & Consulting presented at the 35th Rhine Knee Regional Meeting on structural biology

Magellan Biologics & Consulting presented at the 35th Rhine Knee Regional Meeting on structural biology: An optimised and simplified CHO-based transient gene expression system for protein target optimisation and for research material production. Jerome Puginier 1,**, Florian Wurm,2,3,*, Artur Rodrigues 1, Vanessa F. 1, Maria Wurm 1,21 Magellan Biologics and Consulting LDA, Torres Novas, Portugal 2 ExcellGene SA, Monthey, Switzerland3 Swiss Federal Institute of Technology Lausanne (EPFL)*corresponding […]